Seer, Inc. (SEER)
Seer, Inc. is a life sciences firm specializing in developing and commercializing advanced technologies designed to unravel the complexities of the proteome. At the core of its offerings is the Proteograph Product Suite, an integrated platform comprising specialized consumables, automated instrumentation, and sophisticated software. This comprehensive solution empowers researchers to conduct advanced proteomic studies across various applications, including therapeutic and diagnostic investigations, as well as clinical trials. The company markets its products exclusively for research applications, serving academic institutions, diverse life sciences and research laboratories, and biopharmaceutical and biotechnology enterprises. Notably, these offerings are intended for non-diagnostic and non-clinical purposes. Seer has established collaborative agreements with entities such as Discovery Life Sciences, LLC, and the Salk Institute for Biological Studies. Originally incorporated in 2017 as Seer Biosciences, Inc., the company adopted its current name, Seer, Inc., in July 2018. Its headquarters are situated in Redwood City, California.
Sector: Laboratory Analytical Instruments
Industry: Biotechnology
Seer, Inc.
NASDAQ:SEERHealthcare · Biotechnology
-13.40%$1.68
AH$1.70+1.19%vs close
Mkt Cap$93.02M
Float32.53M
O/S55.37M
Vol
$ Vol
RVOL
Inst Own37.0%
SI0.3%
Earnings
Dilution
Financials Summary
Revenue$16.12M
Net Income-$73.6M
Total Assets$296.08M
Free Cash Flow-$46.24M
Debt & Equity
Debt 8%
Equity 92%
Total Debt$23.65M
Total Equity$259.31M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in SEER's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$296.08M
Liabilities$36.78M
Accounts Receivable$5.95M
Accounts Payable$5.61M
Inventory$7.79M
PP&E (Net)$35.24M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Revenue | $16.12M | $13.95M | $15.18M | $14.69M | $6.39M | $656K | $116K | $0 |
| YoY Growth | 15.6% | -8.1% | 3.4% | 129.7% | 874.7% | 465.5% | - | - |
| Cost of Revenue | $8.11M | $7.12M | $13.73M | $14.3M | $6.77M | $1.61M | $701K | $100K |
| Gross Profit | $8.01M | $6.83M | $1.45M | $384K | -$374K | -$950K | -$585K | -$100K |
| Gross Margin | 49.7% | 49.0% | 9.5% | 2.6% | -5.8% | -144.8% | -504.3% | - |
| Research and Development | $43.87M | $50.59M | $47.44M | $45.8M | $29.12M | $17.34M | $11.69M | $3.68M |
| Selling, General, and Administrative | $42.58M | $56.57M | $58.95M | $52.63M | $42.2M | $15.36M | $4.61M | $2.98M |
| Other | -$459K | -$223K | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $86M | $106.93M | $106.39M | $98.43M | $71.32M | $32.7M | $16.3M | $6.66M |
| Operating Income (EBIT) | -$77.99M | -$100.1M | -$104.94M | -$98.04M | -$71.7M | -$33.65M | -$16.88M | -$6.76M |
| Operating Margin | -483.9% | -717.7% | -691.2% | -667.6% | -1121.3% | -5129.4% | -14554.3% | - |
| Interest Expense | $0 | $0 | $0 | $0 | $22K | $0 | $5K | $0 |
| Interest Income | $11.52M | $16.67M | $17.76M | $4.6M | $326K | $883K | $850K | $451K |
| Other Income (Expense) | $4.59M | $13.6M | $18.66M | $5.08M | $527K | $874K | $845K | $451K |
| Income Before Tax (EBT) | -$73.4M | -$86.5M | -$86.28M | -$92.97M | -$71.17M | -$32.77M | -$16.04M | -$6.31M |
| Income Tax Expense | $201K | $98K | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$73.6M | -$86.6M | -$86.28M | -$92.97M | -$71.17M | -$32.77M | -$16.04M | -$6.31M |
| Net Income Margin | -456.6% | -620.9% | -568.3% | -633.1% | -1113.1% | -4996.2% | -13825.9% | - |
| Supplementary Data | ||||||||
| EPS | -1.28 | -1.39 | -1.35 | -1.42 | -1.13 | -0.51 | -0.26 | -0.29 |
| Diluted EPS | -1.28 | -1.39 | -1.35 | -1.42 | -1.13 | -0.51 | -0.26 | -0.29 |
| Weighted Average OS | 57.45M | 62.35M | 63.85M | 62.43M | 60.86M | 60.91M | 60.91M | 21.45M |
| EBITDA | -$71.89M | -$80.33M | -$80.7M | -$89.02M | -$68.61M | -$31.17M | -$15.33M | -$6.28M |
| EBITDA Margin | -446.0% | -575.9% | -531.5% | -606.2% | -1073.1% | -4751.4% | -13217.2% | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and Cash Equivalents | $47.28M | $40.75M | $32.5M | $53.21M | $232.81M | $333.58M | $17.48M | $30.95M |
| Short-Term Investments | $138.61M | $195.66M | $283.73M | $368.03M | $167.26M | $98.28M | $68.53M | $0 |
| Cash and Short-Term Investments | $185.9M | $236.41M | $316.22M | $421.24M | $400.07M | $431.86M | $86.02M | $30.95M |
| Accounts Receivable | $5.95M | $6.23M | $6.72M | $7.02M | $4.14M | $262K | $326K | $69K |
| Inventory | $7.79M | $7.44M | $4.49M | $4.63M | $4.14M | $551K | $0 | $0 |
| Other Current Assets | $1.89M | $3.25M | $3.08M | $2.1M | $0 | $452K | $0 | $0 |
| Total Current Assets | $201.53M | $253.32M | $330.51M | $434.98M | $411.7M | $433.13M | $86.81M | $31.21M |
| Long-Term Assets | ||||||||
| Property, Plant & Equipment Net | $35.24M | $41.37M | $47.37M | $46.41M | $33.23M | $8.44M | $5.69M | $2.36M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $54.69M | $63.1M | $56.86M | $5.16M | $93.19M | $343K | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $4.62M | $8.8M | $1.53M | $1.38M | $1.02M | $407K | $743K | $124K |
| Total Long-Term Assets | $94.55M | $113.27M | $105.76M | $52.95M | $127.44M | $9.19M | $6.43M | $2.48M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $296.08M | $366.6M | $436.27M | $487.93M | $539.14M | $442.32M | $93.24M | $33.7M |
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts Payable | $5.61M | $4.62M | $1.37M | $2.1M | $3.79M | $2.12M | $701K | $2.63M |
| Short-Term Debt | $0 | $2.31M | $2.29M | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $471K | $501K | $335K | $457K | $0 | $0 | $0 |
| Current Unearned Revenue | $341K | $408K | $206K | $133K | $376K | $250K | $175K | $0 |
| Other Current Liabilities | $5.63M | $1.54M | $2.73M | $6.35M | $4.73M | $2.86M | $1.6M | $344K |
| Total Current Liabilities | $15.69M | $15.33M | $13.22M | $12.58M | $13.42M | $8.09M | $3.81M | $3.69M |
| Long-Term Liabilities | ||||||||
| Long-Term Debt | $21.08M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $8K | $48K | $179K | $320K | $341K | $2.62M | $1.74M | $30K |
| Total Long-Term Liabilities | $21.09M | $23.7M | $26.14M | $28.35M | $22.8M | $2.62M | $1.74M | $30K |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $36.78M | $39.03M | $39.37M | $40.94M | $36.22M | $10.71M | $5.56M | $3.72M |
| Stockholders' Equity | ||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $107.95M | $35.81M |
| Common Stock | $1K | $1K | $1K | $1K | $1K | $1K | $0 | $0 |
| Retained Earnings | -$465.97M | -$392.37M | -$305.77M | -$219.5M | -$126.53M | -$55.36M | -$22.59M | -$6.55M |
| Comprehensive Income & Other | $459K | $136K | -$192K | -$1.25M | -$536K | $54K | $24K | -$31K |
| Other Stockholders' Equity | $725.28M | $719.94M | $702.68M | $666.49M | $629.45M | $486.97M | $110.27M | $36.52M |
| Total Equity | $259.31M | $327.57M | $396.9M | $446.99M | $502.92M | $431.61M | $87.68M | $29.98M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $296.08M | $366.6M | $436.27M | $487.93M | $539.14M | $442.32M | $93.24M | $33.7M |
| Supplementary Data | ||||||||
| Total Debt | $23.65M | $25.96M | $28.26M | $29.87M | $23.32M | $0 | $0 | $0 |
| Net Debt | -$23.63M | -$14.79M | -$4.24M | -$23.33M | -$209.49M | -$333.58M | -$17.48M | -$30.95M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Operating Activities | ||||||||
| Net Income | -$73.6M | -$86.6M | -$86.28M | -$92.97M | -$71.17M | -$32.77M | -$16.04M | -$6.31M |
| Depreciation & Amortization | $6.1M | $6.18M | $5.58M | $3.94M | $2.56M | $1.61M | $701K | $31K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $1.2M | $0 | -$259K | $0 |
| Stock-Based Compensation | $15.41M | $28.21M | $34.42M | $33.67M | $25.93M | $7.35M | $1.56M | $672K |
| Changes in Working Capital: | ||||||||
| Accounts Receivable | $277K | $487K | $302K | -$2.87M | -$2.5M | $64K | -$257K | -$69K |
| Inventory | -$2.9M | -$2.67M | -$1.95M | -$1.59M | -$3.59M | -$551K | $257K | $0 |
| Accounts Payable | $1.06M | $3.35M | -$987K | -$1.55M | $1.6M | $912K | $218K | $323K |
| Other Working Capital | $983K | -$1.32M | -$91K | -$1.07M | -$1.38M | $2.3M | $743K | $630K |
| Total Working Capital Change | -$579K | -$144K | -$2.72M | -$7.09M | -$5.87M | $2.72M | $961K | $953K |
| Other Non-Cash Items | $8.21M | $6.25M | -$10.07M | $1.66M | $1M | $271K | $5K | $0 |
| Net Cash from Operating | -$44.45M | -$46.11M | -$59.06M | -$60.78M | -$46.35M | -$20.83M | -$13.07M | -$4.65M |
| Investing Activities | ||||||||
| Capital Expenditures | -$1.8M | -$3.58M | -$7.31M | -$10.27M | -$6.92M | -$4.53M | -$4.13M | -$168K |
| Acquisitions | $0 | $0 | $0 | $0 | $163.96M | -$50K | $68.25M | $0 |
| Purchases of Investments | -$173.17M | -$272.93M | -$403.09M | -$366.27M | -$279.96M | -$87.72M | -$92M | $0 |
| Sales of Investments | $237.81M | $342.02M | $448.31M | $253.65M | $116M | $57.75M | $23.75M | $0 |
| Other Investing Activities | -$1.3M | $343K | $0 | $170K | -$163.96M | $0 | -$68.25M | $0 |
| Net Cash from Investing | $61.55M | $65.86M | $37.9M | -$122.72M | -$170.88M | -$34.56M | -$72.38M | -$168K |
| Financing Activities | ||||||||
| Debt Repaid | - | - | - | - | - | - | - | - |
| Common Stock Issuance | $458K | $0 | $0 | $0 | $102.96M | $315.34M | $0 | $51K |
| Common Stock Repurchases | -$10.2M | -$11.82M | -$13K | -$20K | -$35K | -$13K | -$6K | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$827K | $321K | $465K | $3.91M | $13.71M | $1.26M | $406K | $29.95M |
| Net Cash from Financing | -$10.57M | -$11.49M | $452K | $3.89M | $116.63M | $371.49M | $72.33M | $29.95M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $6.53M | $8.25M | -$20.71M | -$179.6M | -$100.59M | $316.1M | -$13.13M | $25.13M |
| Supplementary Data | ||||||||
| Operating Cash Flow | -$44.45M | -$46.11M | -$59.06M | -$60.78M | -$46.35M | -$20.83M | -$13.07M | -$4.65M |
| Capital Expenditure | -$1.8M | -$3.58M | -$7.31M | -$10.27M | -$6.92M | -$4.53M | -$4.13M | -$168K |
| Free Cash Flow | -$46.24M | -$49.69M | -$66.37M | -$71.05M | -$53.27M | -$25.36M | -$17.2M | -$4.82M |
| Cash at Beginning | $41.28M | $33.02M | $53.73M | $233.34M | $333.93M | $17.83M | $30.95M | $5.83M |
| Cash at End | $47.81M | $41.28M | $33.02M | $53.73M | $233.34M | $333.93M | $17.83M | $30.95M |